In the partnership with DNDi on ASAQ development, Sanofi-Aventis  (now: Sanofi) contributed resources and expertise in 5 main fields: alt

 

Industrial pharmaceutical development

Development of processes required to reach production on an industrial scale at the Maphar Sanofi-Aventis plant in Casablanca, Morocco.

Scientific

Pre-clinical pharmaco-toxicology studies were designed to further document the safety profile of AS+AQ in animals, as per the latest international requirements.

Regulatory

Preparation of registration files for Morocco, sub-Saharan malaria endemic countries and WHO pre-qualification process.

Application for the inclusion on the WHO Essential Medicines List.

Marketing

Preparation of ASAQ launch and marketing in endemic countries, through private and public distribution channels.

Medical

Preparation and implementation of follow-up clinical studies.